Provided by Tiger Trade Technology Pte. Ltd.

AtriCure

28.88
-1.1600-3.86%
Post-market: 28.880.00000.00%17:20 EDT
Volume:304.58K
Turnover:8.83M
Market Cap:1.44B
PE:-120.46
High:30.14
Open:29.72
Low:28.83
Close:30.04
52wk High:43.18
52wk Low:28.29
Shares:49.72M
Float Shares:47.93M
Volume Ratio:0.58
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2397
EPS(LYR):-0.2400
ROE:-2.40%
ROA:-0.93%
PB:2.92
PE(LYR):-120.33

Loading ...

Top Atricure Executive Makes Notable Insider Move in Latest Stock Trade

TIPRANKS
·
Mar 17

AtriCure Chief Scientific Officer Vinayak Doraiswamy disposes of USD 149,150 in common shares

Reuters
·
Mar 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Atricure (ATRC), Q32 Bio (QTTB) and Shoulder Innovations, Inc. (SI)

TIPRANKS
·
Mar 11

AtriCure to Participate in the Citizens Life Sciences Conference

Reuters
·
Feb 24

AtriCure FY 2025 pain management revenue hits USD 81.92 million, up 32.5%

Reuters
·
Feb 20

AtriCure Earnings Call Highlights Growth Amid Headwinds

TIPRANKS
·
Feb 19

AtriCure Inc. Releases Transcript of Q4 and Full Year 2025 Earnings Conference Call

Reuters
·
Feb 19

UBS Adjusts AtriCure Price Target to $55 From $60, Maintains Buy Rating

MT Newswires Live
·
Feb 19

Stock Track | AtriCure Plummets 5.55% Intraday Amid Analyst Downgrades and Competition Concerns

Stock Track
·
Feb 18

AtriCure : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
Feb 18

Oppenheimer Downgrades AtriCure to Market Perform From Outperform

MT Newswires Live
·
Feb 18

Stock Track | AtriCure Soars 7.67% in Pre-market Following Strong Q4 Earnings Beat and Positive Analyst Outlook

Stock Track
·
Feb 18

AtriCure: Sustained Outperformance, Manageable Competition, and Undervalued Growth Support Buy Rating and $54 Target

TIPRANKS
·
Feb 18

Oppenheimer downgrades AtriCure on new competition from Edwards

TIPRANKS
·
Feb 18

AtriCure downgraded to Perform from Outperform at Oppenheimer

TIPRANKS
·
Feb 18

AtriCure price target lowered to $52 from $60 at Citizens

TIPRANKS
·
Feb 18

AtriCure Price Target Maintained With a $54.00/Share by BTIG

Dow Jones
·
Feb 18

Why AtriCure (ATRC) Is Down 12.9% After Issuing 2026 Profitability Guidance And Revenue Outlook

Simply Wall St.
·
Feb 18

Stock Track | AtriCure Soars 9.19% in Post-Market on Strong Q4 Earnings Beat and Positive 2026 Outlook

Stock Track
·
Feb 18

Stock Track | AtriCure Soars 13.44% After-Hours on Strong Q4 Earnings Beat and Positive 2026 Outlook

Stock Track
·
Feb 18